![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 27, 20896-20902, July 7, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Internal Medicine and Molecular Science,
Graduate School of Medicine, Osaka University, 2-2 Yamadaoka, Suita,
565-0871, Japan
Received for publication, February 8, 2000, and in revised form, March 27, 2000
Adipose tissue is a major site of glycerol
production in response to energy balance. However, molecular basis of
glycerol release from adipocytes has not yet been elucidated. We
recently cloned a novel member of the aquaporin family, aquaporin
adipose (AQPap), which has glycerol permeability. The current study was designed to examine the hypothesis that AQPap serves as a glycerol channel in adipocytes. Adipose tissue expressed AQPap mRNA in high
abundance, but not the mRNAs for the other aquaglyceroporins, AQP3
and AQP9, indicating that AQPap is the only known aquaglyceroporin expressed in adipose tissue. Glycerol release from 3T3-L1 cells was
increased during differentiation in parallel with AQPap mRNA levels
and suppressed by mercury ion, which inhibits the function of AQPs,
supporting AQPap functions as a glycerol channel in adipocytes. Fasting
increased and refeeding suppressed adipose AQPap mRNA levels in
accordance with plasma glycerol levels and oppositely to plasma insulin
levels in mice. Insulin dose-dependently suppressed AQPap
mRNA expression in 3T3-L1 cells. AQPap mRNA levels and adipose glycerol concentrations measured by the microdialysis technique were
increased in obese mice with insulin resistance. Accordingly, negative
regulation of AQPap expression by insulin was impaired in the
insulin-resistant state. Exposure of epinephrine translocated AQPap
protein from perinuclear cytoplasm to the plasma membrane in 3T3-L1
adipocytes. These results strongly suggest that AQPap plays an
important role in glycerol release from adipocytes.
Aquaporins (AQPs),1
which are channel-forming integral proteins, function as water channels
(1). To date, at least 10 AQPs have been identified and cloned in
mammalian tissues actively transporting water molecules, including AQP0
in lens fiber cells (2), AQP1 in erythrocytes (3), AQP2 (4), AQP3 (5, 6), and AQP6 (7) in the kidney, AQP4 in the brain (8), AQP5 in lacrimal
and salivary glands (9), AQP7 in the testis (10), AQP8 in the pancreas
(11) and testis (12), and AQP9 in the liver (13). These AQPs regulate
water movement and are involved in the correction of the osmotic
pressure gradient. The fact that mutations in the AQP2 gene cause
nephrogenic diabetes insipidus in humans has emphasized the importance
of the molecule on regulating water balance (14). Previously, we
isolated a novel cDNA belonging to the AQP family from the human
adipose tissue cDNA library and revealed that its mRNA was
expressed abundantly in human adipose tissue (15). Therefore, we named
it aquaporin adipose (AQPap).
Functional studies have distinguished the members of AQP family into
two subgroups: aquaporins which are selective water channels, and
aquaglyceroporins which transport glycerol as well as water (16). In
our previous study (15), injection of AQPap cRNA into
Xenopus oocytes exhibited permeability to glycerol as well as water, indicating that AQPap belongs to the aquaglyceroporin group.
Glycerol is one of the essential nutrients in the mammalian body. In
fasting, triglyceride in adipocytes is hydrolyzed to glycerol and free
fatty acid (FFA) by hormone-sensitive lipase (HSL) and both are
released into the bloodstream. Organs expressing glycerokinase, such as
the liver and kidney, take up glycerol and use it for gluconeogenesis
to maintain plasma glucose levels (17, 18). It had been believed that
transport of liberated fatty acids from adipocytes was achieved by
simple diffusion (19). However, recent studies have identified several
membrane proteins that transport FFA in adipocytes. These include fatty
acid transport protein (FATP) (19, 20), plasma membrane fatty
acid-binding protein (21), and fatty acid translocase (19, 22). In
contrast, the molecular mechanism underlying glycerol transport across
the cell membrane has not yet been elucidated. A specific molecule(s) is thought to participate in facilitating glycerol transport from the
cell similar to FFA transport. AQPap mRNA is expressed
predominantly in adipose tissue in humans. In the current study, we
examined the regulation of AQPap in both animals and tissue culture.
The results strongly suggest that AQPap is the physiological glycerol channel specific to adipocytes.
Animals and Cells--
Eight-week-old male C57BL/6J, C57BL/KsJ
(db+/+m), and C57BL/KsJ (db+/db+) mice
were purchased from Clea Japan, Inc. The animals were kept at a
constant room temperature with a 12 h dark-light cycle (8 a.m.-8
p.m.). They were acclimated to the new environment for 1 week before
the experiment. A mouse 3T3-L1 cell line was purchased from Health
Science Research Resources Bank (Osaka, Japan, cell number JCRB9014).
Cells were maintained and differentiated with 5 µg/ml insulin, 0.5 mM 1-methyl-3-isobutylxanthin, 1 µM dexamethazone according to the modified method of Rubin et
al. (23).
Cloning of Mouse cDNA Probes and RNA Analysis--
Mouse
AQPap, AQP3, AQP9, HSL, and perilipin (derived from sequences common to
both perilipin A and B) cDNAs were synthesized by the reverse
transcription-polymerase chain reaction using mouse fat tissue (AQPap,
HSL, and perilipin) (24), kidney (AQP3) and liver (AQP9) RNAs as
templates and used as probes for Northern blot analysis. The nucleotide
sequence of mouse AQP3 and AQP9 has been deposited in DDBJ under
accession number AB019039 and AB037180, respectively. Mouse Expression of AQPs mRNAs in Mouse Tissues--
Tissue
distribution of AQPap, AQP3, and AQP9 mRNAs was examined in
9-week-old male C57BL/6J mice. Overnight fasted mice were anesthetized
by 5 mg/ml pentobarbital sodium salt and killed. Various tissues were
removed and used for RNA isolation. The pooled RNA samples from each
tissue were used for Northern analysis. Effect of fasting and feeding
on AQPap mRNA expression in adipose tissue was examined in male
C57BL/KsJ (db+/+m) mice (n = 8, each). The
fed group was given free access to standard laboratory chow and the
fasted group was fasted for 18 h before killing. For the experiment on the time course of fasting and refeeding, male C57BL/6J mice (each group, n = 3) were given free access to
standard laboratory chow and tap water for 12 h after 24 h
fasting to strictly determine the starting point of fasting. Actual
fasting was started at 6 a.m. (the zero time). The fasted group
was fasted for 12 (6 p.m.) or 18 (0 a.m.) hours before killing. The
refed group was given free access to standard laboratory chow for
12 h after 18 h fasting. All mice were phlebotomized from the
vena cava quickly. Plasma glycerol, FFA, and insulin were measured by
the UV method (Roche Molecular Biochemicals, sensitivity >1
µM), Nescauto NEFA kit (Azwell, Japan), and a
double-antibody sandwich enzyme immunoassay using a Glazyme Insulin EIA
Kit (Sanyo Chemical Industries, Ltd., Japan) with rat insulin as a
standard, respectively. Subcutaneous fat tissues were removed and used
for RNA isolation. AQPap mRNA expression in adipose tissue of obese
C57BL/KsJ (db+/db+) mice was compared with that of their
lean littermate C57BL/KsJ (db+/+m) mice (n = 8, each).
Measurement of Glycerol Concentration in Subcutaneous Fat
Tissue--
Glycerol concentration in subcutaneous fat tissues was
measured by a microdialysis technique (27, 28). C57BL/KsJ
(db+/db+) and (db+/+m) mice (n = 7, each) were brought to the laboratory at 8 a.m. under ad
libitum feeding and drinking condition. During the experiments,
the mice were anesthetized and warmed with heating pads to maintain the
body temperature at about 35-37° C. The microdialysis probes were
hand-made (10 × 0.2 mm, 50,000 molecular weight cut-off). The
recovery rate in the probes was calculated by in vitro
experiments prior to the study. During dialysis, the probe and catheter
were connected to a microinfusion pump (CMA102, BAS) and perfused with Krebs-Ringer solution. The dialysis probe was inserted into the inguinal subcutaneous fat tissue and perfusion with Krebs-Ringer solution (2 µl/min) was started. The blood samples were drawn from
the jugular vein. Fractions of dialysate were collected every 30 min.
The first and second fractions were discarded because of a transient
rise in the concentration of glycerol in response to the initial
trauma. The in vitro recovery rate of glycerol was
approximately 70%. Glycerol concentration in the perfusate was
measured by a fluorometric/colorimetric enzyme method (29).
Glycerol Release from 3T3-L1 Cells--
3T3-L1 cells on day 9 after differentiation were washed twice with phosphate-buffered saline
(PBS) without calcium and magnesium ions, and incubated with
Dulbecco's modified Eagle's medium (DMEM) containing 0.5% fatty
acid-free bovine serum albumin (BSA) (Sigma) supplemented with and
without 10 Effects of Hormones on AQPap Expression in 3T3-L1
Cells--
3T3-L1 cells on day 9 were used for the experiments on the
effects of hormones on AQPap expression (30). Cells were washed twice
with PBS and incubated with DMEM containing 0.5% BSA for 12 h.
After washing twice with PBS, the cells were incubated in DMEM
containing 0.5% BSA supplemented with or without 10 Generation of Anti-peptide Antibodies and Immunocytochemical
Detection of AQPap--
Polyclonal rabbit antiserum was raised against
the carboxyl terminus of mouse AQPap. We designed two synthetic
peptides containing YLGLIHPSIPQDPQRLENF and NFTARDQKVTAS (with
NH2-terminal cystein added in the latter synthetic amino
acid peptide) because they were divergent among the AQP family. The
specificity of antisera was confirmed by immunoblotting. For
immunoblotting, crude membrane fractions of 3T3-L1 cells and mouse
adipose tissues were prepared as follows. For 3T3-L1 cells, the cells
were homogenized in buffer containing 20 mM Tris-HCl (pH
7.4), 1 mM EDTA, 255 mM sucrose, 1 mM phenylmethylsulfonyl fluoride, and 1 µg/ml leupeptin,
then centrifuged at 8,000 × g for 10 min at 4° C.
The supernatant was recentrifuged at 100,000 × g,
yielding a pellet containing crude membranes and a supernatant
containing cytosol. For adipose tissues, the membrane fractions were
obtained by the method of Oka et al. (31, 32). The proteins
(40 µg) from each fraction were loaded and separated on a 12.5%
sodium dodecyl sulfate-polyacrylamide gel and transferred to
polyvinylidene difluoride membrane. Western blot analysis was performed
using antiserum to AQPap at a dilution of 1:500. Horseradish
peroxidase-coupled donkey anti-rabbit immunogloblins were used at a
dilution of 1:3000. Detection by chemiluminescence was performed using
ECLTM system (Amersham Pharmacia Biotech).
For immunocytochemical detection, 3T3-L1 adipocytes were differentiated
on glass coverslips and analyzed on day 13 after differentiation. Cells
were incubated with or without 10 Statistical Analysis--
The results were expressed as
mean ± S.E. The significance of the difference between the mean
values of the groups was evaluated by Student's t test or
analysis of variance (ANOVA) with Fisher's PLSD test.
Tissue Distribution of Aquaglyceroporins mRNAs in
Mice--
Tissue distribution of AQPap was examined in pooled RNA
samples of overnight fasted mice by Northern blotting. Mouse AQPap mRNA was expressed predominantly in white and brown adipose tissues (Fig. 1). Much fainter signals were
observed in kidney and skeletal (gastrocunemius) muscle. The expression
pattern was similar to that in human tissues as previously reported
(15). We also examined the expression of mRNAs for AQP3 and AQP9,
which are other members of aquaglyceroporins shown to have the ability
to transport glycerol. The results of Northern blotting showed that
white and brown adipose tissues did not have any detectable amounts of
AQP3 and AQP9 mRNAs (Fig. 1). Therefore, AQPap is the sole
aquaglyceroporin among the known AQPs.
Effect of Fasting and Refeeding on AQPap mRNA
Expression--
Fasting activates lipolysis and accelerates glycerol
release from adipose tissue. We investigated the effect of fasting on AQPap mRNA expression in white adipose tissues. Mice fasted for 18 h exhibited remarkably higher levels of adipose AQPap mRNA compared with the fed mice (Fig.
2a). The time course of AQPap mRNA levels during fasting and refeeding were examined. Plasma glycerol and FFA levels were elevated in the fasted mice and decreased in the refed mice. Plasma insulin levels were decreased in the fasted
mice and restored in the refed mice. White adipose AQPap mRNA
levels were increased by fasting and suppressed by refeeding (Fig.
2b). The changes of mRNAs for AQPap and HSL showed a
similar pattern to that of plasma glycerol and FFA.
Glycerol Concentration and AQPap mRNA Levels in Adipose Tissues
of Obese Mice--
Glycerol metabolism is dysregulated in obesity with
insulin resistance (33). Plasma glycerol concentration is elevated in obesity and non-insulin-dependent diabetes mellitus. We
compared metabolic parameters in obese db+/db+ mice and
their lean littermate, db+/+m mice. Plasma glycerol
concentration (512 ± 32 µM versus 259 ± 37 µM, p < 0.001) and FFA
concentration (1.03 ± 0.08 mM versus
0.51 ± 0.04 mM, p < 0.001) were
elevated in the obese mice (Fig. 3)
despite hyperinsulinemia. Glycerol concentration in the interstitial
fluid of adipose tissue more precisely reflects the amount of glycerol
release from adipocytes than that in plasma. Accordingly, we measured
the glycerol concentration in the interstitial fluid of adipose tissue
by the microdialysis technique. Adipose tissue glycerol concentrations
were higher in obese mice than in lean mice (82 ± 11 µM versus 49 ± 5 µM,
p < 0.01) (Fig. 3). White adipose AQPap mRNA
levels in obese animals were approximately 4-fold higher than those in
lean animals (p < 0.001) (Fig. 3). Obese mice also
showed elevated HSL mRNA levels (p < 0.05). Thus, AQPap and HSL mRNAs were overexpressed in mice with insulin
resistance.
Expression of AQPap mRNA in 3T3-L1 Cells--
Next, we
examined the time course of glycerol release activity and expression of
the genes relating to lipolysis during the differentiation of cultured
3T3-L1 cells. The amount of epinephrine-stimulated glycerol release per
hour was measured in 3T3-L1 cells each day after differentiation.
Glycerol in the medium became detectable from day 4 after
differentiation, increased during differentiation, and reached a
plateau level on day 13 (Fig. 4).
Undifferentiated 3T3-L1 cells did not express AQPap mRNA. The
signal of AQPap mRNA was detectable in the cells on day 3 after
differentiation, and increased in parallel with glycerol release
activity. It is known that perilipin associates with the surface of
intracellular neutral lipid droplets and controls lipolysis (24, 34).
The expression patterns of perilipin and HSL mRNAs after
differentiation were similar to that of AQPap mRNA (Fig. 4).
Neither AQP3 nor AQP9 mRNA were detected in the differentiated
3T3-L1 cells (data not shown).
Hormonal Regulation of AQPap mRNA in 3T3-L1 Cells--
AQPap
mRNA expression was augmented in the fasted mice with low levels of
plasma insulin and suppressed in the refed mice with elevated plasma
insulin levels. We hypothesized that AQPap mRNA would be negatively
regulated by insulin. The effect of insulin on AQPap mRNA
expression was investigated in the differentiated 3T3-L1 cells.
Administration of insulin dose-dependently suppressed AQPap
mRNA expression in 3T3-L1 adipocytes on day 9 after differentiation (Fig. 5a). Treatment with
10 Immunological Detection of AQPap Protein in 3T3-L1 Cells and
Adipose Tissues--
To investigate the regulation and subcellular
localization of AQPap at the protein level, we raised an antibody
against the carboxyl terminus of AQPap. The specificity of the antibody
was assessed by immunoblotting (Fig.
6a). The antibody recognized a
single band at 28 kDa corresponding to the predicted molecular mass of
AQPap in the crude membrane fraction (M) of differentiated 3T3-L1 adipocytes (lane 4), but not in the soluble cytosolic
fraction (C) (lane 3) consistent with the fact
that AQPap is an integral membrane protein. The band could not be
observed by preimmune serum (lane 2) and was abolished by
the presence of excess immunizing synthetic peptide (lane
6). The AQPap protein was detected in the differentiated 3T3-L1
cells (Fig. 6b, lane 2), but not in the undifferentiated
3T3-L1 cells (lane 1). The AQPap protein levels were higher
in adipose tissue of the fasted mice (lane 4) compared with
those in the fed mice (lane 3). Obese mice showed higher
levels of adipose AQPap protein (lane 6) compared with those
in lean mouse (lane 5).
Subcellular localization of AQPap protein was studied in the
differentiated 3T3-L1 cells by confocal immunocytoscopy. AQPap immunoreactivity was detected in the intracellular region around the
nucleus with a scattered pattern (Fig. 6c). When the cells were stimulated by 10 Glycerol Release from 3T3-L1 Cells--
The water and glycerol
permeability of most aquaporins is inhibited by mercury ions by
affecting the cysteine residue near the well conserved NPA
(Asn-Pro-Ala) motif, which takes part in the channel forming process
(36). We previously reported that the osmotic water permeability in
AQPap-expressing Xenopus oocytes was inhibited by
HgCl2 and that this inhibition was recovered by the
addition of 2-mercaptoethanol similar to the other AQPs (15). The
effect of mercury ions on glycerol release in 3T3-L1 cells was
investigated. We tested various concentrations of HgCl2 on
epinephrine-stimulated glycerol release from the cells. Administration of HgCl2 at concentrations greater than 10 µM
effectively suppressed glycerol release (Fig.
7a). Treatment of 10 mM 2-mercaptoethanol recovered the inhibition of glycerol
release between the concentration of 10 and 40 µM of
HgCl2 (Fig. 7a). The inhibition of glycerol release by HgCl2 was also confirmed by a separate
experiment. Glycerol release was reduced to 19% by the addition of 30 µM HgCl2 (control versus
HgCl2, p < 0.0001) and was restored by the
supplementation of 2-mercaptoethanol (ME) (HgCl2 + ME
versus HgCl2, p < 0.0001) (Fig.
7b). The addition of 2-mercaptoethanol alone did not affect the amount of glycerol released (data not shown). These data suggest that glycerol release from adipocytes is facilitated through AQPap, which is the only detectable aquaglyceroporin in adipocytes.
Adipose tissue is a major site of glycerol production and
secretion (37). Molecules responsible for glycerol release from adipocytes, however, have not yet been elucidated. Recently using the
cDNA library from human adipose tissue, we have identified a novel
member of the AQP family. As the mRNA of this AQP was expressed
most abundantly in adipose tissue, we termed it AQPap (15). Although
some members of the AQP family possess permeability to small molecules,
including urea and glycerol as well as water, the physiological
significance has been obscure. In the current study using mice, we
demonstrated that 1) AQPap was the only aquaglyceroporin expressed in
adipocytes, 2) fasting enhanced and refeeding suppressed its mRNA
expression in adipose tissue, 3) adipose AQP mRNA was overexpressed
in obese mice with elevated adipose glycerol concentration. These data
prompted us to hypothesize that AQPap functions as a glycerol channel
in adipocytes. This hypothesis is supported by the result that glycerol
release from adipocytes was mercury sensitive.
Insulin is the major hormone that suppresses lipolysis (38). Adipose
expression of AQPap mRNA was enhanced in fasted mice whose insulin
levels in plasma had decreased. Long-term fasting has been found to
increase HSL mRNA levels in adipose tissues in rats (39). FATP
expression is also augmented by fasting and is thought to facilitate
fatty acid efflux from the adipose cell during lipolysis (40).
Administration of insulin reduced the expression of AQPap in
dose-dependent and time course-dependent manners in 3T3-L1 adipocytes. It had been shown that insulin negatively regulates the expression of HSL and FATP genes (40, 41). Coordinated regulation of HSL, FATP, and AQPap expression will be beneficial for
the effective release of FFA and glycerol from adipocytes.
The suppression of AQPap mRNA expression by feeding was impaired in
obese mice with insulin resistance. Consistent with this finding, we
have observed that the interstitial glycerol concentration in
subcutaneous fat tissue was elevated in obese mice using the microdialysis technique. It has been reported that glycerol production in fat tissue was increased in human obesity (33). Hyperglycerolemia is
a frequent finding of obesity and is often associated with increased
rates of lipolysis (33). Increased glycerol turnover rate in obesity
contributes to increased hepatic glucose production, resulting in
hyperglycemia (42-44). Impaired suppression of AQPap in the
insulin-resistant state may be involved in increased hepatic glucose
output through hyperglycerolemia.
In non-stimulated 3T3-L1 cells, AQPap immunoreactivity was detected in
the perinuclear cytoplasm with a scattered distribution, suggesting
that AQPap resides in the intracellular vesicles. After stimulation of
epinephrine for 20 min, the intensity of AQPap signals in the plasma
membrane was increased. These findings suggest that AQPap protein was
translocated from the intracellular vesicles to the plasma membrane.
Among the members of the AQP family, AQP2 is located on the principal
cells of the renal collecting duct and translocated from the
intracellular vesicles to plasma membrane by short exposure to
arginine-vasopressin (45). Phosphorylation of AQP2 through the protein
kinase A cascade triggers the translocation of AQP2 (46). In
adipocytes, binding of epinephrine to adrenergic receptors
phosphorylates HSL at several serine residues and activates the enzyme
through the protein kinase A pathway (47, 48). Taken together, it is
possible that protein kinase A may be involved in the translocation of
AQPap.
In conclusion, AQPap is the only aquaglyceroporin that transports
glycerol into adipose tissue. Studies on mRNA regulation strongly
suggest that AQPap is responsible for the nutritional effect on plasma
glycerol and that the disturbed regulation of AQPap mRNA is crucial
for hyperglycerolemia in the insulin-resistant state.
We thank Yuko Matsukawa and Sachiyo Tanaka of
our laboratory and Yasuji Furutani and Mayumi Ohue (Dainippon
Pharmaceutical Co. Ltd.) for helpful technical assistance.
*
This work was supported in part by the fund from the
"Research for the Future" Program from the Japan Society for the
Promotion of Science: JSPS-RFTF97L00801 and Ministry of Education,
Science, Sports and Culture of Japan Grants-in-aid 09307019, 10557100, 10557101, and 10671035.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The nucleotide sequence of mouse AQP3 and AQP9 has been submitted
to the DDBJ/GenBandTM/EBI Data Bank with accession numbers
AB019039 and AB037180, respectively.
§
To whom correspondence should be addressed: Dept. of Internal
Medicine and Molecular Science, Graduate School of Medicine, Osaka
University, 2-2 Yamadaoka, Suita, 565-0871, Japan. Tel.: 81-6-6879-3732; Fax: 81-6-6879-3739; E-mail:
tohru@imed2.med.osaka-u.ac.jp.
Published, JBC Papers in Press, April 20, 2000, DOI 10.1074/jbc.M001119200
The abbreviations used are:
AQP, aquaporin;
AQPap, aquaporin adipose;
HSL, hormone-sensitive lipase;
FATP, fatty
acid transport protein;
FFA, free fatty acid;
PBS, phosphate-buffered
saline;
DMEM, Dulbecco's modified Eagle's medium;
BSA, bovine serum
albumin;
cAMP, cyclic adenosine 3',5'-monophosphate;
ME, 2-mercaptoethanol;
ACTH, adrenocorticotropic hormone.
Aquaporin Adipose, a Putative Glycerol Channel in Adipocytes*
,
,
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-actin
cDNA was purchased from Stratagene Ltd. Total cellular RNA was
prepared with TRIZOLTM reagent kit (Life Technologies,
Inc.). Northern blot analysis and RNase protection assay were performed
as described previously (25, 26).
6 M epinephrine for 1 h at
37° C (30). Glycerol concentration in the media was measured by the
UV method. The effect of mercury ions on glycerol release was tested as
follows. 3T3-L1 cells on day 9 after differentiation were washed twice
with PBS followed by incubation with PBS containing various
concentration of HgCl2 for 5 min. After incubation, the
cells were washed and further incubated with or without 10 mM 2-mercaptoethanol for 30 min at room temperature. After
washing twice with PBS, the cells were incubated with PBS containing
0.5% BSA and 10
6 M epinephrine for 1 h
at 37° C. The concentration of glycerol in the incubated buffer was
measured as described above.
9,
10
8, 10
7, and 10
6
M bovine insulin for 6 h. For the experiment on time
course, cells were incubated in DMEM with 10
8
M insulin for 0, 3, or 6 h. Total RNA was isolated and
used for Northern blotting and RNase protection assay.
6 M
epinephrine for 20 min at 37° C. After washing with PBS, cells were
fixed with 4% paraformaldehyde for 30 min on ice, permeabilized with
0.1% Triton X-100 for 5 min on ice, washed extensively with PBS,
blocked with 5% normal swine serum for 30 min, and incubated with
antiserum to AQPap serum at a dilution of 1:500 in PBS containing 5%
BSA for 1 h at room temperature. Cells were washed with PBS and
incubated with biotinylated swine serum to anti-rabbit immunogloblins in PBS containing 5% BSA for 30 min at room temperature. After washing
with PBS, the cells were incubated with fluorescein
isothiocyanate-conjugated avidin D for 30 min at room temperature.
After extensive washing with PBS, the cells were examined by confocal
microscopy and photographed.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (72K):
[in a new window]
Fig. 1.
Tissue distribution of mRNAs for AQPs in
mice. Total RNAs from various tissues of overnight fasted C57BL/6J
mice were subjected to Northern blot analysis (10 µg/lane). The blots
were hybridized with AQPap, AQP3, and AQP9 cDNA probes.
Lowest panel represents the ethidium bromide-stained 28 S
ribosomal RNAs in the blot.

View larger version (47K):
[in a new window]
Fig. 2.
Effect of fasting and feeding on AQPap
mRNA expression. a, white adipose tissues from C57BL/KsJ
(db+/+m) mice after 18 h fasting or feeding
(n = 8, each) were removed and used for Northern blot
analysis of AQPap mRNA. Total RNA (10 µg) prepared from an
individual mouse was applied to each lane. b, time course of
metabolic parameters, AQPap and HSL mRNA expressions during fasting
and refeeding were examined in white adipose tissue of C57BL/6J mice.
Mice were killed after 0, 12, and 18 h fasting or after 12 h
refeeding, then white adipose tissues were removed for analysis of
AQPap and HSL mRNA. Abundance of mRNAs was determined by
densitometric analysis and represented by arbitrary units. Plasma
glycerol, FFA, and insulin were measured and the data were represented
by the mean ± S.E.

View larger version (30K):
[in a new window]
Fig. 3.
Plasma glycerol, adipose tissue glycerol
concentrations and AQPap mRNA levels in lean and obese mice.
Obese db+/db+ (n = 7) and lean
db+/+m mice (n = 7) were allowed to feed
ad libitum. After anesthetization, adipose tissue was
microdialyzed for 90 min and the perfusates were collected every 30 min. Blood samples were taken at the midpoint of the collection period.
Concentrations of glycerol in plasma and perfusates were measured by
the fluorometric/colorimetric enzyme method. Total RNA (10 µg) of
subcutaneous fat tissues in obese db+/db+ (n = 8) and lean db+/db+ (n = 8) mice were
analyzed by Northern blotting. Representative Northern blots using
pooled RNA samples are shown in the insets.
Columns and bars represent the mean ± S.E.
for the results. *, p < 0.001; **, p < 0.01; ***, p < 0.05, lean versus obese,
Student's t test.

View larger version (27K):
[in a new window]
Fig. 4.
Time course of epinephrine-stimulated
glycerol release, AQPap, HSL, and perilipin mRNA expression during
differentiation of 3T3-L1 cells. a, 3T3-L1 cells on the
indicated day after the induction of differentiation were incubated
with 10
6 M epinephrine for 1 h. Glycerol
concentration in media was measured by the UV method. b-d,
total RNA (10 µg/lane) was extracted from 3T3-L1 cells on the
indicated day after differentiation-inducing treatment. Northern blot
analysis was performed using AQPap, HSL, and perilipin cDNA probes.
We repeated the experiment three times. Representative data are
indicated.
9 M insulin decreased AQPap mRNA levels
by 43%. The time course of AQPap mRNA suppression by insulin was
also investigated. Incubation with 10
8 M
insulin for 3 h significantly suppressed AQPap mRNA levels and
6 h incubation resulted in 45% suppression (Fig. 5b).
Therefore, insulin is a negative regulator of AQPap expression. We also
investigated the effect of lipolytic hormones on AQPap mRNA levels.
Administration of epinephrine, glucagon, and ACTH, however, did not
change AQPap mRNA levels in the differentiated 3T3-L1 cells (data
not shown). These results were also consistent with a previously
reported finding that these hormones did not affect HSL mRNA levels
(35).

View larger version (22K):
[in a new window]
Fig. 5.
Effect of insulin on AQPap mRNA
expression. 3T3-L1 cells on day 9 were preincubated with DMEM
containing 0.5% BSA for 12 h. After washing, the cells were
incubated with DMEM containing 0.5% BSA and the indicated
concentration of insulin for 6 h (a) or
10
8 M insulin for 0, 3, or 6 h
(b). RNAs samples (5 µg/lane) were subjected to RNase
protection assay (a) and Northern blot analysis
(b). a: lane 1, undigested probe;
lane 2, yeast RNA control; lanes 3-7, samples
with indicated insulin concentration.

View larger version (31K):
[in a new window]
Fig. 6.
Localization of AQPap protein in 3T3-L1
cells. a, the crude membrane (M) and cytosolic
fractions (C) of differentiated 3T3-L1 cells on day 7 were subjected to
sodium dodecyl sulfate-polyacrylamide gel electrophoresis and Western
blotting. Immunoblot analysis was performed using preimmune serum
(lanes 1 and 2), polyclonal antibody against the
carboxyl terminus of mouse AQPap (lanes 3 and 4)
and polyclonal antibody supplemented with synthetic peptide
(lanes 5 and 6), respectively. The positions of
the molecular weight markers are indicated on the left.
b, membrane fractions were prepared from undifferentiated
3T3-L1 cells (lane 1), differentiated 3T3-L1 cells on day 9 (lane 2), subcutaneous adipose tissue of the fed (lane
3), fasted (lane 4), lean (lane 5), or obese
(lane 6) mice. Immunoblot analysis of AQPap protein was
performed. Representative immunoblotting is shown. c, for
immunocytochemical detection of AQPap protein, 3T3-L1 cells on day 7 were treated with or without 10
6 M
epinephrine for 20 min at 37° C. After washing, the cells were
fixed, permeabilized with 0.1% Triton X-100, and incubated with
antiserum to AQPap or preimmune serum. After incubation with
biotinylated swine serum, followed by fluorescein
isothiocyanate-conjugated avidin D, cells were examined by confocal
microscopy and photographed.
6 M epinephrine for 20 min, the signals in the plasma membrane became robust in comparison
with those in the intracellular regions (Fig. 6c),
suggesting that AQPap was translocated from intracellular regions to
the plasma membrane.

View larger version (15K):
[in a new window]
Fig. 7.
Inhibition of glycerol release in 3T3-L1
cells by HgCl2. 3T3-L1 cells on day 9 after
differentiation were incubated with PBS containing various
concentrations of HgCl2. After washing, the cells were
further incubated with (open circle) or without
(closed circle) 10 mM ME for 30 min at room
temperature. Next, the cells were incubated with PBS containing 0.5%
BSA and 10
6 M epinephrine for 1 h at
37° C. Concentrations of glycerol in media were measured as
described under "Experimental Procedures." Statistical analysis was
performed by ANOVA. The mean ± S.E. (n = 4) for
the results was represented by a column and bar
graph. *, p < 0.0001: control versus
HgCl2; **, p < 0.0001: HgCl2 + ME versus HgCl2.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES
Contributed equally to the results of this work.
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Knepper, M. A.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
6255-6258
2.
Gorin, M. B.,
Yancey, S. B.,
Cline, J.,
Revel, J. P.,
and Horwitz, J.
(1984)
Cell
39,
49-59
3.
van Hoek, A. N.,
and Verkman, A. S.
(1992)
J. Biol. Chem.
267,
18267-18269
4.
Fushimi, K.,
Uchida, S.,
Hara, Y.,
Hirata, Y.,
Marumo, F.,
and Sasaki, S.
(1993)
Nature
361,
549-552
5.
Ishibashi, K.,
Sasaki, S.,
Fushimi, K.,
Uchida, S.,
Kuwahara, M.,
Saito, H.,
Furukawa, T.,
Nakajima, K.,
Yamaguchi, Y.,
Gojobori, T.,
and Marumo, F.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
6269-6273
6.
Echevarria, M.,
Windhager, E. E.,
Tate, S. S.,
and Frindt, G.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
10997-11001
7.
Ma, T.,
Frigeri, A.,
Skach, W.,
and Verkman, A. S.
(1993)
Biochem. Biophys. Res. Commun.
197,
654-659
8.
Jung, J. S.,
Bhat, R. V.,
Preston, G. M.,
Guggino, W. B.,
Baraban, J. M.,
and Agre, P.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
13052-13056
9.
Raina, S.,
Preston, G. M.,
Guggino, W. B.,
and Agre, P.
(1995)
J. Biol. Chem.
270,
1908-1912
10.
Ishibashi, K.,
Kuwahara, M.,
Gu, Y.,
Kageyama, Y.,
Tohsaka, A.,
Suzuki, F.,
Marumo, F.,
and Sasaki, S.
(1997)
J. Biol. Chem.
272,
20782-20786
11.
Koyama, Y.,
Yamamoto, T.,
Kondo, D.,
Funaki, H.,
Yaoita, E.,
Kawasaki, K.,
Sato, N.,
Hatakeyama, K.,
and Kihara, I.
(1997)
J. Biol. Chem.
272,
30329-30333
12.
Ishibashi, K.,
Kuwahara, M.,
Kageyama, Y.,
Tohsaka, A.,
Marumo, F.,
and Sasaki, S.
(1997)
Biochem. Biophys. Res. Commun.
237,
714-718
13.
Tsukaguchi, H.,
Shayakul, C.,
Berger, U. V.,
Mackenzie, B.,
Devidas, S.,
Guggino, W. B.,
van Hoek, A. N.,
and Hediger, M. A.
(1998)
J. Biol. Chem.
273,
24737-24743
14.
Deen, P. M.,
Verdijk, M. A.,
Knoers, N. V.,
Wieringa, B.,
Monnens, L. A.,
van Os, C. H.,
and van Oost, B. A.
(1994)
Science
264,
92-95
15.
Kuriyama, H.,
Kawamoto, S.,
Ishida, N.,
Ohno, I.,
Mita, S.,
Matsuzawa, Y.,
Matsubara, K.,
and Okubo, K.
(1997)
Biochem. Biophys. Res. Commun.
241,
53-58
16.
Froger, A.,
Tallur, B.,
Thomas, D.,
and Delamarche, C.
(1998)
Protein Sci.
7,
1458-1468
17.
Klein, S.,
Holland, O. B.,
and Wolfe, R. R.
(1990)
Am. J. Physiol.
258,
E32-39
18.
Baba, H.,
Zhang, X. J.,
and Wolfe, R. R.
(1995)
Nutrition
11,
149-153
19.
Motojima, K.,
Passilly, P.,
Peters, J. M.,
Gonzalez, F. J.,
and Latruffe, N.
(1998)
J. Biol. Chem.
273,
16710-16714
20.
Schaffer, J. E.,
and Lodish, H. F.
(1994)
Cell
79,
427-436
21.
Stremmel, W.,
Strohmeyer, G.,
Borchard, F.,
Kochwa, S.,
and Berk, P. D.
(1985)
Proc. Natl. Acad. Sci. U. S. A.
82,
4-8
22.
Ibrahimi, A.,
Sfeir, Z.,
Magharaie, H.,
Amri, E. Z.,
Grimaldi, P.,
and Abumrad, N. A.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
2646-2651
23.
Rubin, C. S.,
Hirsch, A.,
Fung, C.,
and Rosen, O. M.
(1978)
J. Biol. Chem.
253,
7570-7578
24.
Greenberg, A. S.,
Egan, J. J.,
Wek, S. A.,
Moos, M. C., Jr.,
Londos, C.,
and Kimmel, A. R.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
12035-12039
25.
Shimomura, I.,
Funahashi, T.,
Takahashi, M.,
Maeda, K.,
Kotani, K.,
Nakamura, T.,
Yamashita, S.,
Miura, M.,
Fukuda, Y.,
Takemura, K.,
Tokunaga, K.,
and Matsuzawa, Y.
(1996)
Nat. Med.
2,
800-803
26.
Kihara, S.,
Ouchi, N.,
Funahashi, T.,
Shinohara, E.,
Tamura, R.,
Yamashita, S.,
and Matsuzawa, Y.
(1998)
Atherosclerosis
136,
163-168
27.
Arner, P.,
Bolinder, J.,
Eliasson, A.,
Lundin, A.,
and Ungerstedt, U.
(1988)
Am. J. Physiol.
255,
E737-742
28.
Arner, P.,
and Bolinder, J.
(1991)
J. Intern. Med.
230,
381-386
29.
Winartasaputra, H.,
Mallet, V. N.,
Kuan, S. S.,
and Guilbault, G. G.
(1980)
Clin. Chem.
26,
613-617
30.
Chernick, S. S.,
Spooner, P. M.,
Garrison, M. M.,
and Scow, R. O.
(1986)
J. Lipid. Res.
27,
286-294
31.
Oka, Y.,
Asano, T.,
Lin, J. L.,
Tsukuda, K.,
Katagiri, H.,
Ishihara, H.,
Inukai, K.,
and Yazaki, Y.
(1992)
Gerontology.
38,
3-9
32.
Oka, Y.,
Asano, T.,
Shibasaki, Y.,
Kasuga, M.,
Kanazawa, Y.,
and Takaku, F.
(1988)
J. Biol. Chem.
263,
13432-13439
33.
Jansson, P. A.,
Larsson, A.,
Smith, U.,
and Lonnroth, P.
(1992)
J. Clin. Invest.
89,
1610-1617
34.
Greenberg, A. S.,
Egan, J. J.,
Wek, S. A.,
Garty, N. B.,
Blanchette-Mackie, E. J.,
and Londos, C.
(1991)
J. Biol. Chem.
266,
11341-11346
35.
Slavin, B. G.,
Ong, J. M.,
and Kern, P. A.
(1994)
J. Lipid Res.
35,
1535-1541
36.
Preston, G. M.,
Jung, J. S.,
Guggino, W. B.,
and Agre, P.
(1993)
J. Biol. Chem.
268,
17-20
37.
Ramsay, T. G.
(1996)
Endocrinol. Metab. Clin. North Am.
25,
847-870
38.
O'Brien, R. M.,
and Granner, D. K.
(1996)
Physiol. Rev.
76,
1109-1161
39.
Sztalryd, C.,
and Kraemer, F. B.
(1994)
Am. J. Physiol.
266,
E179-185
40.
Man, M. Z.,
Hui, T. Y.,
Schaffer, J. E.,
Lodish, H. F.,
and Bernlohr, D. A.
(1996)
Mol. Endocrinol.
10,
1021-1028
41.
Botion, L. M.,
and Green, A.
(1999)
Diabetes
48,
1691-1697
42.
Bergman, R. N.,
and Mittelman, S. D.
(1998)
J. Basic Clin. Physiol. Pharmacol.
9,
205-221
43.
Puhakainen, I.,
Koivisto, V. A.,
and Yki-Jarvinen, H.
(1992)
J. Clin. Endocrinol. Metab.
75,
789-794
44.
Nurjhan, N.,
Consoli, A.,
and Gerich, J.
(1992)
J. Clin. Invest.
89,
169-175
45.
Nielsen, S.,
Chou, C. L.,
Marples, D.,
Christensen, E. I.,
Kishore, B. K.,
and Knepper, M. A.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
1013-1017
46.
Kuwahara, M.,
Fushimi, K.,
Terada, Y.,
Bai, L.,
Marumo, F.,
and Sasaki, S.
(1995)
J. Biol. Chem.
270,
10384-10387
47.
Honnor, R. C.,
Dhillon, G. S.,
and Londos, C.
(1985)
J. Biol. Chem.
260,
15130-15138
48.
Anthonsen, M. W.,
Ronnstrand, L.,
Wernstedt, C.,
Degerman, E.,
and Holm, C.
(1998)
J. Biol. Chem.
273,
215-221
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
V. Ceperuelo-Mallafre, M. Miranda, M. R. Chacon, N. Vilarrasa, A. Megia, C. Gutierrez, J. M. Fernandez-Real, J. M. Gomez, E. Caubet, G. Fruhbeck, et al. Adipose Tissue Expression of the Glycerol Channel Aquaporin-7 Gene Is Altered in Severe Obesity But Not in Type 2 Diabetes J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3640 - 3645. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Akabane, Y. Ogushi, T. Hasegawa, M. Suzuki, and S. Tanaka Gene cloning and expression of an aquaporin (AQP-h3BL) in the basolateral membrane of water-permeable epithelial cells in osmoregulatory organs of the tree frog Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2007; 292(6): R2340 - R2351. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Skowronski, J. Lebeck, A. Rojek, J. Praetorius, E.-M. Fuchtbauer, J. Frokiaer, and S. Nielsen AQP7 is localized in capillaries of adipose tissue, cardiac and striated muscle: implications in glycerol metabolism Am J Physiol Renal Physiol, March 1, 2007; 292(3): F956 - F965. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tsukada, Y. Tanaka, H. Maegawa, A. Kashiwagi, R. Kawamori, and S. Maeda Intronic Polymorphisms within TFAP2B Regulate Transcriptional Activity and Affect Adipocytokine Gene Expression in Differentiated Adipocytes Mol. Endocrinol., May 1, 2006; 20(5): 1104 - 1111. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Sohara, T. Rai, J.-i. Miyazaki, A. S. Verkman, S. Sasaki, and S. Uchida Defective water and glycerol transport in the proximal tubules of AQP7 knockout mice Am J Physiol Renal Physiol, December 1, 2005; 289(6): F1195 - F1200. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. A. MacDougald and C. F. Burant Obesity and metabolic perturbations after loss of aquaporin 7, the adipose glycerol transporter PNAS, August 2, 2005; 102(31): 10759 - 10760. [Full Text] [PDF] |
||||
![]() |
T. Hibuse, N. Maeda, T. Funahashi, K. Yamamoto, A. Nagasawa, W. Mizunoya, K. Kishida, K. Inoue, H. Kuriyama, T. Nakamura, et al. From The Cover: Aquaporin 7 deficiency is associated with development of obesity through activation of adipose glycerol kinase PNAS, August 2, 2005; 102(31): 10993 - 10998. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hara-Chikuma, E. Sohara, T. Rai, M. Ikawa, M. Okabe, S. Sasaki, S. Uchida, and A. S. Verkman Progressive Adipocyte Hypertrophy in Aquaporin-7-deficient Mice: ADIPOCYTE GLYCEROL PERMEABILITY AS A NOVEL REGULATOR OF FAT ACCUMULATION J. Biol. Chem., April 22, 2005; 280(16): 15493 - 15496. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Martikainen, J. J. Tenhunen, I. Giovannini, A. Uusaro, and E. Ruokonen Epinephrine induces tissue perfusion deficit in porcine endotoxin shock: evaluation by regional CO2 content gradients and lactate-to-pyruvate ratios Am J Physiol Gastrointest Liver Physiol, March 1, 2005; 288(3): G586 - G592. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Maeda, T. Funahashi, T. Hibuse, A. Nagasawa, K. Kishida, H. Kuriyama, T. Nakamura, S. Kihara, I. Shimomura, and Y. Matsuzawa Adaptation to fasting by glycerol transport through aquaporin 7 in adipose tissue PNAS, December 21, 2004; 101(51): 17801 - 17806. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Ajuwon and M. E. Spurlock Direct regulation of lipolysis by interleukin-15 in primary pig adipocytes Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2004; 287(3): R608 - R611. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Carbrey, D. A. Gorelick-Feldman, D. Kozono, J. Praetorius, S. Nielsen, and P. Agre Aquaglyceroporin AQP9: Solute permeation and metabolic control of expression in liver PNAS, March 4, 2003; 100(5): 2945 - 2950. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kuriyama, I. Shimomura, K. Kishida, H. Kondo, N. Furuyama, H. Nishizawa, N. Maeda, M. Matsuda, H. Nagaretani, S. Kihara, et al. Coordinated Regulation of Fat-Specific and Liver-Specific Glycerol Channels, Aquaporin Adipose and Aquaporin 9 Diabetes, October 1, 2002; 51(10): 2915 - 2921. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hansen, J. F. J. Kun, J. E. Schultz, and E. Beitz A Single, Bi-functional Aquaglyceroporin in Blood-stage Plasmodium falciparum Malaria Parasites J. Biol. Chem., February 8, 2002; 277(7): 4874 - 4882. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Whitacre, S. Chauhan, T. Davis, D. Gordon, A. E. Cress, and R. L. Miesfeld Androgen Induction of in Vitro Prostate Cell Differentiation Cell Growth Differ., January 1, 2002; 13(1): 1 - 11. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kishida, I. Shimomura, H. Nishizawa, N. Maeda, H. Kuriyama, H. Kondo, M. Matsuda, H. Nagaretani, N. Ouchi, K. Hotta, et al. Enhancement of the Aquaporin Adipose Gene Expre |